Shutao Zheng

9PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHuman impacts of climate change and human adaptationMetabolic medicinePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 17, 2025
5-FU Resistance Facilitates Immune Evasion in Esophageal Squamous Cell Carcinoma Through ADAM10-Mediated PD-L1 Shedding and Tumour Microenvironment Remodelling.

Bangwu Cai, Xiaowen Feng, Shujuan Luo

|Jul 17, 2024
NME4 suppresses NFκB2-CCL5 axis, restricting CD8+ T cell tumour infiltration in oesophageal squamous cell carcinoma.

Shutao Zheng, Shuo He, Yan Liang

|Apr 14, 2024
Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example.

Shutao Zheng, Shuo He, Yan Liang

|Nov 26, 2022
Small Tweaks, Major Changes: Post-Translational Modifications That Occur within M2 Macrophages in the Tumor Microenvironment.

Shutao Zheng, Yan Liang, Yiyi Tan

|May 28, 2022
Revisiting the Old Data of Heat Shock Protein 27 Expression in Squamous Cell Carcinoma: Enigmatic HSP27, More Than Heat Shock.

Shutao Zheng, Yan Liang, Lu Li

|Apr 09, 2021
Posttranslational modification of pyruvate kinase type M2 (PKM2): novel regulation of its biological roles to be further discovered.

Shutao Zheng, Qing Liu, Tao Liu

Pageof 2

Frequent Collaborators

2 joint publications

Qing Liu